What does the scale‐up of long‐acting HIV pre‐exposure prophylaxis mean for the global hepatitis B epidemic?

What does the scale‐up of long‐acting HIV pre‐exposure prophylaxis mean for the global hepatitis B epidemic?

Abstract Introduction The HIV and hepatitis B virus (HBV) epidemics are interconnected with shared routes of transmission and specific antiviral drugs that are effective against both viruses. Nearly, 300 million people around the world live with chronic HBV, many of whom are from priority population...

Full description

Bibliographic Details
Main Authors: Amir M. Mohareb, Menan Gérard Kouamé, Marcellin Nouaman, Arthur Y. Kim, Joseph Larmarange, Anne M. Neilan, Karine Lacombe, Kenneth A. Freedberg, Anders Boyd, Patrick Coffie, Emily P. Hyle
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Journal of the International AIDS Society
Subjects:
cabotegravir
hepatitis B
hepatitis
HIV
long‐acting antiretroviral therapy
long‐acting PrEP
Online Access:https://doi.org/10.1002/jia2.26218

Similar Items

Similar Items